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FIGURE 2. A, Image from head end showing aortotomy and transfemoral 26-mm Edwards Sapien TAVI valve being prepared for positioning under direct
vision. B, Close-up view through aortotomy showing TAVI valve after successful deployment.
Case Reportspatients.3 The combination of transaortic TAVI and coro-
nary bypass surgery also has been reported.4 We describe
a case in which the extent of circumferential aortic calcifi-
cation presented a considerable technical challenge for
conventional aortic valve surgery, but in a patient in
whom LAD disease also was believed to be very difficult
to manage by percutaneous coronary intervention. It there-
fore was decided, given our familiarity with TAVI, that we
should make use of the transfemoral TAVI valve and deliv-
ery system to replace the aortic valve at the same time the
left internal thoracic artery to LAD was performed, thus
avoiding the requirement for suturing at the level of the
dense aortic calcification. The utility of a TAVI valve inFrom the Vascular Surgery Unit, Department ‘‘Paride Stefanini,’’ Sapienza University
of Rome, Rome, Italy.
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e54 The Journal of Thoracic and Cardiovascular Surgthis case highlights the potential in clinical practice for su-
tureless aortic valve prostheses.
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vasc Surg. 2013;145:600-2.Four-year follow-up after thoracic endovascular aortic repair for
symptomatic thoracoabdominal aneurysm through the off-label use
of a bifurcated abdominal endograftMario Marino, MD, Holta Kasemi, MD, Enrico Sbarigia, MD, and Francesco Speziale, MD, Rome, ItalyThoracic endovascular aortic repair has become an alterna-
tive to the open surgical or to the hybrid approach for thor-
acoabdominal aortic aneurysm (TAAA) treatment.1
Fenestrated and branched endografts allow the exclusionof the aneurysm and perfusion of the visceral arteries. Un-
fortunately, these devices require from 4 to 6 weeks for
manufacture, an unsafely long wait for a symptomatic or
ruptured TAAA. In an emergency setting, the use of off-
the shelf devices of standardized design permits treatment
of more than 80% of TAAAs.2 Homemade devices have
been reported for urgent TAAA repair.3 In addition, the
chimney and sandwich endovascular techniques remain a
valid alternative for patients with symptomatic or ruptured
TAAA.
We report the 4-year follow-up of a high-risk patient with
symptomatic TAAA treated with an unusual endovascular
technique: off-label use of a device manufactured for in-
frarenal aortic aneurysm repair.ery c December 2013
FIGURE 1. Preoperative computed tomographic scan.
Case ReportsCLINICAL SUMMARY
A 69-year-old man in hemodynamically stable condition
came to our emergency department with chest and back
pain. His medical history revealed hypertension, chronic
renal failure, chronic obstructive pulmonary disease, severe
postischemic dilated cardiomyopathy (ejection fraction
18%), and cardiac defibrillator use. Seven years previously,
the patient had undergone a gastroduodenal artery emboli-
zation and gastroduodenal resection because of digestive
tract bleeding.
Contrast-enhanced computed tomographic angiog-
raphy demonstrated a TAAA 7 cm in diameter
(Figure 1). The superior mesenteric artery (SMA) and
the renal arteries originated from a healthy aortic portion.
The proximal neck length of the infrarenal portion of the
TAAAwas 35 mm (aneurysmal diameter 8 cm). Endovas-
cular aneurysmal exclusion in the emergency setting was
offered to the patient. Written, informed consent and
institutional review board approval were obtained before
the procedure.
With local anesthesia, after systemic heparinization and
through an open right femoral approach, a selective angio-
gram demonstrated no collateral supply of the celiac
trunk. A bifurcated endograft (Endurant ENBF
3216C120; Medtronic Inc, Minneapolis, Minn) was de-
ployed 7 cm distal to the left subclavian artery. The ipsi-
lateral limb was extended to the celiac trunk with a
straight endograft (Endurant ENLW 1610C95; Medtronic),
and a covered stent-graft (Viabahn 11 3 100 mm; W. L.
Gore and Associates Inc, Flagstaff, Ariz) was deployed
subsequently through an open left subclavian access
(Figure 2, A).
Through an open left femoral approach, the contralat-
eral leg was extended with Endurant and Valiant endog-
rafts (ENLW 1628C80EE and VAMC 3232B100TE;
Medtronic) just proximal to the SMA. Angiography
showed a type Ib endoleak that needed a distal cuff
deployment (Excluder 320400; Gore). The infrarenal
portion of the aneurysm was treated with the Excluder
endograft (PXT 311415, ipsilateral limb PXC 201000,
contralateral limb PXL 161207, and PXC 201200;
Gore).
The completion angiography demonstrated complete
aneurysmal exclusion, with no signs of endoleak and with
patency of the celiac trunk, SMA, and renal arteries. The
procedure lasted 280 minutes, 180 mL contrast medium
was administered, and the total fluoroscopy time was 117
minutes.
No difference between the upper and lower limb blood
pressures caused by a coarctation similar to the congen-
ital coarctation due to the endografts deployed in the
thoracic portion was registered. No variation of the liquor
pressure was observed. The postoperative course wasThe Journal of Thoracic and Cauneventful, and the patient was discharged on the fifth
postoperative day with oral antiplatelet therapy (aspirin
at 100 mg/d).
The patient underwent computed tomographic scan con-
trol at 1 month follow-up and yearly thereafter. The 4-year
follow-up computed tomographic scan confirmed complete
aneurysmal exclusion, with no signs of endoleak and com-
plete visceral vessel patency (Figure 2, B).DISCUSSION
Surgical or hybrid TAAA repair was not feasible in our
case because of the patient’s comorbidities and the absence
of collateral supply of the celiac trunk from the SMA.
Moreover, custom device manufacture required too much
time, and at the time we did not have enough experience
with homemade devices. A chimney or periscope technique
was not performed because thoracic endograft oversizingrdiovascular Surgery c Volume 146, Number 6 e55
FIGURE 2. A, Immediate postoperative computed tomographic scan shows thoracic bifurcated endograft (a), straight Endurant endograft into the ipsilat-
eral thoracic endograft limb (b), Viabahn stent graft to revascularize the celiac trunk (c), and contralateral thoracic endograft limb extended to the superior
mesenteric artery (d). B, Late postoperative (4-year follow-up) computed tomographic scan shows thoracic endovascular aneurysmal exclusion (a), infrare-
nal endovascular aneurysmal exclusion (b), patent celiac trunk (c), and patent superior mesenteric artery (d).
Case Reportsgreater than 30% was necessary. This could increase the
risk of a coarctation similar to the congenital coarctation
along the ipsilateral leg of the bifurcated endograft in the
thoracic aorta.
Various types of endografts were selected after consid-
ering the vessels’ tortuosity, the radial forces, and the diam-
eter and length of the aneurysmal aorta. The high costs of
the entire procedure were justified by the results obtained,
especially at 4 years follow-up.
To our knowledge, this case 4 years ago was the first of
TAAA treated with a bifurcated abdominal endograft de-
ployed in the thoracic aorta. Recently, Kasirajan4 reported
the parallel endograft octopus technique with 2 bifurcated
endografts in the thoracic aorta.
In conclusion, in strictly selected patients, the off-label
use of available materials by high-ability, skilled operatorse56 The Journal of Thoracic and Cardiovascular Surgoffers a valid therapeutic option for patients who would
otherwise remain untreated. Long surveillance is necessary
to detect potential complications or procedure failure and
correct them promptly.References
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